Codexis (NASDAQ: CDXS) CSO Lutz sells 4,685 shares to cover tax liability
Rhea-AI Filing Summary
Codexis, Inc. CSO Stefan Lutz reported selling 4,685 shares of Codexis common stock on January 7, 2026 at a price of $1.6968 per share. According to the disclosure, this sale was made to cover tax liabilities arising from the vesting and release of restricted stock units held by him. After this transaction, Lutz beneficially owned 138,775 shares of Codexis common stock, which includes 41,633 restricted stock units, all held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 4,685 | $1.6968 | $8K |
Footnotes (2)
- F1. The sale reported on this Form 4 was effected to cover tax liability incurred due to the vesting and release of Restricted Stock Units held by the Reporting Person.
- F2. Includes 41,633 restricted stock units.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Codexis (CDXS) report for Stefan Lutz?
Codexis reported that CSO Stefan Lutz sold 4,685 shares of its common stock on January 7, 2026 at $1.6968 per share.
What type of security did Stefan Lutz sell in this Codexis Form 4 filing?
The transaction involved Codexis common stock, reported as a non-derivative security in the Form 4 filing.
Is the Stefan Lutz transaction in Codexis (CDXS) stock direct or indirect ownership?
The filing states that the 4,685 shares sold and the 138,775 shares beneficially owned following the transaction are held under direct ownership.
What role does Stefan Lutz hold at Codexis (CDXS) in this insider filing?
In this Form 4, Stefan Lutz is identified as an officer of Codexis, serving as its Chief Scientific Officer (CSO).